Articles

Poll

Podcasts

Slideshows

Videos

Psychiatry

Psychiatry condition center page is a comprehensive resource for clinical news and insights on mental illnesses. This page consists of interviews, articles, podcasts, and videos on the research, treatment and development of therapies for depression, schizophrenia, bipolar disorder, anxiety, and more.

In an interview, Jacob Ballon, MD, MPH, discusses the significance of his team’s study which found olanzapine and samidorphan was well-tolerable for up to 4 years of treatment for schizophrenia and bipolar disorder treatment.

Jacob Ballon, MD, MPH: Discusses Takeaways from Studying Long-Term Olanzapine and Samidorphan

A study demonstrated olanzapine and samidorphan’s (LYBALVI) safety, tolerability, and durability during a 4-yeat treatment period.

Olanzapine, Samidorphan Effective for Long-Term Schizophrenia, Bipolar Disorder Treatment 

Mothers with mood disorders—either bipolar disorder, major depressive disorder— or schizophrenia/ schizoaffective disorder are not associated with their offspring’s risk for type 1 diabetes. Results suggest mothers with bipolar disorder tend to develop type 1 diabetes, but data is not clinically significant.

Mothers’ Mental Disorders Is Not Linked to Type 1 Diabetes in Offspring

A large systematic review assessing more than 60 drugs for bipolar depression shows only a handful were statistically signifcantly better than placebo per depressive symptom outcomes.

7 Pharmacological Agents That Benefit Acute Bipolar Depression

The findings underscore the importance of considering both the severity of BPD features and changes in depressive symptoms when assessing risk of suicide.

Borderline Personality Disorder Increases Suicide Risk in Depression, Bipolar Disorder

A prospective cohort analysis of Denmark residents suggests correlation between cannabis overuse and risk of psychiatric conditions.

Cannabis Use Disorder Linked to High Bipolar Disorder, Depression Risk

The long-acting injectable can be administered once every 2 months to either treat schizophrenia or serve as a maintenance monotherapy for bipolar disorder.

FDA Approves Bi-Monthly Aripiprazole Injection for Schizophrenia, Bipolar Disorder

Children definite motor problems were more likely to have psychotic experiences compared to children with no definite motor problems.

Early Motor Impairment Could Forecast Schizophrenia, Bipolar Disorder

A new cross-sectional analysis suggest there are few options available for patients with schizophrenia or a serious mood disorder.

Smartphone Mental Health Apps Lack Diverse Features, Consistent Privacy Settings

There was a decrease in relapse observed for low-risk participants, but not high-risk individuals. 

Some Symptom Benefit for Bipolar Patients With Smartphone Program 

The HCPLive bipolar disorder page is a resource for medical news and expert insights on BPD. This page features expert-led coverage, articles, videos and research on the therapies and development of treatments for bipolar disease, and more.